K. Peggs

Immunology · 2006–2023

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Immunology — 68 citations into it; #1,638 of 2,160 by trust here, #377 by citations

Whom K. Peggs trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Sergio A. Quezada

Who trusts K. Peggs overall

1. Sergio A. Quezada
2. Padmanee Sharma
3. D. Pardoll
4. K. Palucka
5. James P. Allison
6. L. Collison
7. S. Topalian

Papers from K. Peggs's perspective

Ordered by how strongly the researchers K. Peggs trusts endorse each paper. Same corpus, a different order for every researcher.

1. Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 (Journal of Experimental Medicine)
2. Modulation of tryptophan catabolism by regulatory T cells (Nature Immunology)
3. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
4. CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. (Journal of Clinical Investigation)
5. Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens (Journal of Clinical Oncology)
6. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. (Journal of Clinical Investigation)
7. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. (Immunity)
8. Foxp3 instability leads to the generation of pathogenic memory T cells in vivo (Nature Immunology)
9. Tumor-specific Th17-polarized cells eradicate large established melanoma. (Blood)
10. Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive… (Journal of Experimental Medicine)

Their papers

• Lung adenocarcinoma promotion by air pollutants (2023) — 655 citations
• ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells (2018) — 3,090 citations
• Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells (2017) — 836 citations
• Phylogenetic ctDNA analysis depicts early stage lung cancer evolution (2017) — 1,635 citations
• Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade (2016) — 2,796 citations
• Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma (2013) — 1,396 citations
• Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts (2010) — 881 citations
• Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies (2009) — 936 citations
• CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. (2006) — 685 citations